Al-Qiami Almonzer, Amro Sarah, Sarhan Khalid, Arafeh Yusra, Milad Mina, Omar Islam, Nashwan Abdulqadir J
Faculty of Medicine and Health Sciences, Kassala University, Kassala, Sudan.
Medical Research Group of Egypt, Negida Academy, Arlington, MA, Egypt.
Neurosurg Rev. 2025 Mar 20;48(1):310. doi: 10.1007/s10143-025-03449-6.
The trigeminocardiac reflex (TCR) is activated when the trigeminal nerve is manipulated through mechanical pressure, traction, or irritation. This leads to a rapid increase in parasympathetic activity, resulting in a decrease in heart rate (HR) and blood pressure, which can potentially lead to bradycardia, and cardiac arrest, with a prevalence of 14.5% during neurointerventional procedures (8). The aim of this study was to assess the effect of lidocaine injection on preventing TCR during cranial surgeries. We conducted a comprehensive search of PubMed, Web of Science, and Cochrane CENTRAL electronic databases for clinical trials comparing the use of lidocaine versus placebo, or no intervention for TCR prevention during cranial surgeries up until 20 May 2024. Meta-analyses were performed using fixed-effects models, and heterogeneity was assessed using I-squared and Chi-square tests. A total of five studies involving 421 patients were included in this meta-analysis. The incidence of TCR was significantly lower in the lidocaine group compared to the control group, with a risk ratio of 0.05 (95% CI 0.01 to 0.37, P = 0.003). Additionally, the lidocaine group had a relatively small change in HR, with a mean difference of -10.56 (95% CI -13.30 to -7.83 beat per minute, P = 0.00001). No statistically significant difference in mean arterial pressure was observed between the two groups (MD -5.15, 95% CI [-10.38 to 0.08 mmHg], P = 0.09). Our results suggest that lidocaine may be effective in preventing TCR and stabilizing HR. The use of lidocaine could be considered a prophylactic measure during cranial surgeries. Further studies are needed to investigate the optimal dose and timing of lidocaine administration.
当通过机械压力、牵引或刺激来操作三叉神经时,三叉神经心脏反射(TCR)就会被激活。这会导致副交感神经活动迅速增加,从而使心率(HR)和血压下降,这可能会导致心动过缓以及心脏骤停,在神经介入手术期间其发生率为14.5%(8)。本研究的目的是评估利多卡因注射在颅脑手术中预防TCR的效果。我们对PubMed、科学网和考科蓝中央电子数据库进行了全面检索,以查找截至2024年5月20日比较利多卡因与安慰剂或无干预措施在颅脑手术中预防TCR的临床试验。使用固定效应模型进行荟萃分析,并使用I²和卡方检验评估异质性。本荟萃分析共纳入了五项涉及421名患者的研究。与对照组相比,利多卡因组TCR的发生率显著更低,风险比为0.05(95%置信区间0.01至0.37,P = 0.003)。此外,利多卡因组的心率变化相对较小,平均差值为-10.56(95%置信区间每分钟-13.30至-7.83次心跳,P = 0.00001)。两组之间未观察到平均动脉压有统计学显著差异(平均差值-5.15,95%置信区间[-10.38至0.08 mmHg]),P = 0.09)。我们的结果表明,利多卡因可能在预防TCR和稳定心率方面有效。在颅脑手术期间,使用利多卡因可被视为一种预防措施。需要进一步研究来探讨利多卡因给药的最佳剂量和时机。